SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,263,800 | -92.8% | 110,000 | -86.3% | 0.01% | -94.4% |
Q3 2022 | $31,391,000 | -22.8% | 801,600 | -36.3% | 0.12% | -27.3% |
Q2 2022 | $40,675,000 | +178.7% | 1,259,300 | +185.6% | 0.17% | +196.6% |
Q1 2022 | $14,597,000 | +1.8% | 441,000 | +30.9% | 0.06% | +1.8% |
Q4 2021 | $14,332,000 | -57.3% | 336,900 | -55.5% | 0.06% | -61.2% |
Q3 2021 | $33,560,000 | +158.9% | 757,400 | +231.9% | 0.15% | +153.4% |
Q2 2021 | $12,964,000 | -48.1% | 228,200 | -31.6% | 0.06% | -50.4% |
Q1 2021 | $24,977,000 | +35.2% | 333,700 | +10.4% | 0.12% | +23.2% |
Q3 2020 | $18,471,000 | +260.8% | 302,214 | +145.4% | 0.10% | +187.9% |
Q2 2020 | $5,120,000 | -79.2% | 123,134 | -52.0% | 0.03% | -72.5% |
Q4 2018 | $24,566,000 | -0.6% | 256,459 | +46.5% | 0.12% | +17.6% |
Q3 2018 | $24,719,000 | +12.8% | 175,000 | +25.0% | 0.10% | +17.2% |
Q2 2018 | $21,914,000 | +32.6% | 140,000 | +36.5% | 0.09% | +26.1% |
Q1 2018 | $16,526,000 | +77.6% | 102,600 | +81.6% | 0.07% | +72.5% |
Q4 2017 | $9,306,000 | -61.2% | 56,500 | -85.3% | 0.04% | -62.6% |
Q3 2017 | $23,957,000 | +140.7% | 384,550 | +207.6% | 0.11% | +91.1% |
Q2 2017 | $9,955,000 | -64.6% | 125,000 | -68.4% | 0.06% | -64.3% |
Q1 2017 | $28,094,000 | +753.1% | 395,300 | +512.9% | 0.16% | +582.6% |
Q4 2016 | $3,293,000 | -57.1% | 64,500 | -61.3% | 0.02% | -57.4% |
Q3 2016 | $7,672,000 | +51.8% | 166,600 | -0.7% | 0.05% | +58.8% |
Q2 2016 | $5,053,000 | – | 167,700 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |